Nesvacumab
Nesvacumab
Nesvacumab (pronounced: nes-va-cu-mab) is a monoclonal antibody designed for the treatment of various types of cancer. It is currently under investigation in clinical trials.
Etymology
The term "Nesvacumab" is derived from the International Nonproprietary Names (INN), where 'mab' at the end suggests it is a monoclonal antibody. 'Nesva' is a unique stem used for naming.
Definition
Nesvacumab is a type of monoclonal antibody that is being studied in the treatment of certain types of cancer. Monoclonal antibodies are made to target and destroy only certain cells in the body, which may help to protect healthy cells from damage.
Usage
Nesvacumab is used in the field of oncology for the treatment of various types of cancer. It is currently in the clinical trial phase.
Related Terms
External links
- Medical encyclopedia article on Nesvacumab
- Wikipedia's article - Nesvacumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski